Press Releases Items Per Page 102550 News Category FinancialGeneral Year None2024202320222021202020192018201720162015201420132012201120102009200820072006 Nektar Therapeutics to Webcast R&D Day on November 14th Nov 13, 2007 Nektar Therapeutics Announces Third Quarter 2007 Financial Results Nov 07, 2007 Nektar to Announce Third Quarter 2007 Financial Results on Wednesday, November 7, 2007, After the Close of U.S. Financial Markets Oct 31, 2007 NKTR-102 (PEG-Irinotecan) Demonstrates Significant Tumor Growth Inhibition In Multiple Preclinical Tumor Models Oct 25, 2007 Nektar Therapeutics Issues Statement on Exubera Oct 18, 2007 Tumor Growth Inhibition and Pharmacokinetic Profile of NKTR-102 (PEG-Irinotecan) in Multiple Solid Tumors To Be Presented at Upcoming AACR-NCI-EORTC International Conference Oct 10, 2007 Nektar Therapeutics President and CEO Howard Robin to Present at 2007 BIO InvestorForum Oct 02, 2007 NKTR-102 (PEG-Irinotecan) Demonstrates Significant Anti-Tumor Activity and Improved Pharmacokinetic Profile in Preclinical Studies Presented at ECCO Sep 27, 2007 Positive Results for NKTR-118 (oral PEG-naloxol) Presented at American Academy of Pain Management Meeting Sep 26, 2007 Nektar Therapeutics Creates New PEGylation and Pulmonary Research Units to Drive Innovative Technology-Based Product Pipeline Sep 18, 2007 Pagination First page « first Previous page ‹ previous … Page 44 Page 45 Page 46 Page 47 Current page 48 Page 49 Page 50 Page 51 Page 52 … Next page next › Last page last »